King Luther Capital Management Corp decreased its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,648 shares of the financial services provider’s stock after selling 420 shares during the period. King Luther Capital Management Corp’s holdings in MetLife were worth $2,428,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the business. Bank of New York Mellon Corp raised its holdings in MetLife by 109.2% during the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after buying an additional 4,606,748 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of MetLife by 1.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Nordea Investment Management AB grew its stake in shares of MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of MetLife by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider’s stock worth $320,430,000 after acquiring an additional 30,187 shares in the last quarter. Finally, Swedbank AB grew its stake in shares of MetLife by 76.0% in the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after acquiring an additional 1,496,645 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Trading Up 1.0 %
Shares of MetLife stock opened at $79.22 on Thursday. MetLife, Inc. has a 52-week low of $67.30 and a 52-week high of $89.05. The stock’s 50-day simple moving average is $83.56 and its 200 day simple moving average is $82.39. The stock has a market capitalization of $53.97 billion, a P/E ratio of 13.27, a P/E/G ratio of 0.65 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.75%. The ex-dividend date was Tuesday, February 4th. MetLife’s payout ratio is presently 36.52%.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on MET. Barclays reduced their target price on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Cowen reiterated a “buy” rating on shares of MetLife in a research note on Friday, March 7th. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, TD Cowen boosted their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.58.
View Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- How to Short Nasdaq: An Easy-to-Follow Guide
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- What is a Stock Market Index and How Do You Use Them?
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Using the MarketBeat Dividend Tax Calculator
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.